허쉬성형외과의원

HERSHE Plastic Surgery Introduces MCT Metacell Following Designation as an Advanced Regenerative Medicine Institution

Hello, this is HERSHE Plastic Surgery.

HERSHE Plastic Surgery has been designated by the Ministry of Health and Welfare of the Republic of Korea as an “Advanced Regenerative Medicine Institution.”

Advanced Regenerative Medicine Institutions are designated by the Ministry of Health and Welfare in accordance with the Act on the Safety of and Support

for Advanced Regenerative Medicine and Advanced Biological Products, based on whether medical institutions meet the required standards for facilities, 

equipment, personnel, and other relevant criteria.

To commemorate this designation, HERSHE Plastic Surgery has displayed the official Advanced Regenerative Medicine Institution Certificate issued by the Ministry of Health and Welfare within the clinic.

Along with this designation, HERSHE Plastic Surgery has further systematized its clinical environment

for regenerative medicine and introduced the MCT Metacell Program, which utilizes autologous blood.

MCT Metacell is a program in which the patient's own blood is collected and separated, followed by the application 

of MCT's PBM technology to activate regenerative-related components in the blood. 

Depending on the individual's condition and treatment plan, it may be administered through methods such as local injections or intravenous (IV) infusion.

In particular, the program may be utilized as part of personalized care that takes into consideration the regenerative environment of various areas, 

including skin condition and elasticity, as well as the scalp and hair.

Building on its accumulated experience in regenerative medicine research, two stem cell-related patents, and its designation as an Advanced Regenerative Medicine Institution,

HERSHE Plastic Surgery plans to continue advancing its research and clinical systems in the field of regenerative medicine.

​

From designation as an Advanced Regenerative Medicine Institution by the Ministry of Health and Welfare to autologous regenerative care with MCT Metacell.

HERSHE Plastic Surgery will continue to comply with established safety management standards, 

carefully assess each individual's condition, and recommend an appropriate direction for regenerative medical care.